Skip To Content

Trian Partners, Like Other Giant Hedge Funds, Is A Big Fan Of The Mystery Stock

Nelson Peltz's giant hedge fund is currently holding a position that makes up 11% of the entire $5.8 billion fund's portfolio, but has not had to reveal what the name of the stock is, even after the quarter's filing deadline has passed. This isn't the first time the SEC has allowed the fund, as well as other large managers, to withhold a major filing, and some smaller activist hedge funds are questioning the fairness of the practice.

The "Poison Pill" Defense Has Its Day In Court

Shareholder rights plans, commonly called "poison pills" because they limit the amount of stock an investor is able to acquire, are increasingly being used by companies against activist investors. But hedge fund manager Dan Loeb is mounting a court challenge to its relevancy in his battle against auction house Sotheby's.